Advertisement Specific types of immune cells unleashed by cancer immunotherapy appear to cause myocarditis, an inflammatory ...

CStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals has unveiled promising preclinical data for ...

Study reveals potential of AI-powered tumor microenvironment assessment in predicting treatment outcomes in rare cancer patients receiving ...

The immune system is a major target for cancer treatments. Immune checkpoint inhibitors and CAR-T cell therapy can ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation. Patients with active disease also had greater abundance of clusters of ...

PD-1 and PD-L1 immune checkpoint inhibitors (ICIs) for treating advanced cancer were associated with an increased risk of new ...

“I’m going to undergo chemotherapy and immunotherapy right away. Cancer can be tough. But so am I. I will attack this the ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis. Researchers have now uncovered the ...